RHYTHM PHARMACEUTICALS, INC. (RYTM) Deferred Tax Assets, Valuation Allowance USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rhythm Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2016 to 2023.
  • Rhythm Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $267 M, a 23% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $267 M +$49.9 M +23% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $217 M +$59 M +37.3% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $158 M +$24.6 M +18.4% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $134 M +$40.7 M +43.7% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $92.9 M +$45.3 M +94.9% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $47.7 M +$23.6 M +98.1% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $24.1 M +$3.59 M +17.5% Dec 31, 2017 10-K 2019-03-08
Q4 2016 $20.5 M Dec 31, 2016 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.